Tech Transfer Timelines: The Hidden Constraint on Manufacturing Flexibility
Day 1 Manufacturing 5.0 Stage
06/10/2026 15:45 - 16:10pm
Contributors
Bernardo Estupinan : Managing Director - CDMO Advisor
Tarik Senussi : Director MSAT Biotech • RD Technology Transfer - Reordati
Tanya Sharma : Co-founder - Assurea
Technology transfer remains a critical execution bottleneck in pharmaceutical manufacturing, with biologics requiring 18-24 months and small molecules 6-18 months for standard transfers. While leading organisations are achieving 6-8 month timelines through AI-driven tools and digital twins, adoption remains limited due to regulatory validation requirements, cost barriers, and organisational readiness gaps. This session examines why tech transfer delays prevent access to otherwise available capacity and what early adopters are achieving in 2025-2026.